2001 Fiscal Year Final Research Report Summary
DEVELOPMENT OF GLUTATHIONE ANALOGUE FOR GHEMOPREVENTION OF CORECTAL CANCER
| Project/Area Number |
12470125
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Sapporo Medical University |
|---|
Principal Investigator |
NIITSU Yoshiro Sapporo Medical University, School of medicine, professor, 医学部, 教授 (10045502)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TANABE Hiroshi TEIJIN PHARMACUITICAL INC. manager, 創薬第二研究所・創薬化学グループ, 統轄
TAKAYAMA Tetsuji Sapporo Medical University, School of medicine, assistant professor, 医学部, 講師 (10284994)
|
|---|
| Project Period (FY) |
2000 – 2001
|
| Keywords | GST-π / ACF / Colorectal cancer / Chemoprevention |
|---|
| Research Abstract |
Aim: We synthesized a new glutathione analogue, a specific inhibitor for Glutathione Stransferase (GST)-π, and examined the chemopreveritive effect on colon carcinogenesis of rat. We also examined if glutathione analogue induce apoptosis in human ACF, a precursor of adenoma-carcinoma sequence. Methods and Results: (1)Selective inhibitor of GST-π, ν-glutamyl-S-(benzyl) cyteinyl phenlyglycine diethyester, was synthesized and purified by HPLC. (2) 20 mg/kg of azoxymethane was injected (day1, i. p.) in rat and.the glutathione analogue was administered (30 mg kg, I.p.) for 3 weeks (day1- 21). The number of ACF in rats treated with glutathione analogue and control rats were 9.8 ± 2.2 and 22.5 ± 4.5, respectively. There was a significant difference between the two groups (p<0.01). (3) Biopsy specimens of ACF were treated with glutathione analogue (10-50μM) in the presence of DCA(1mM) and the TUNEL staining was performed. The percentages of apoptotic cells with glutathione analogue (14.8±4.3%) was significantly higher than that without it (4.2 ± 2.3 %). (4) Acute toxicity of glutathione analogue in mice was examined, and the values of LD 50 were very high (700 - 1000 mg/kg). Conclusion: It was demonstrated that glutathione analogue is a promising chemopreventive agent for colon carcinogenesis.
|
Research Products
(8 results)
-
-
-
[Publications] Sakamaki S., Takayanagi N., Yoshizaki N., Hayashi S, Takayama T, Kato J, Kogawa K,Yamauchi N, Takemoto N, Nobuoka A, Ayabe T, Kohgo Y, Niitsu Y.: "Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells"Gut.. 47. 236-241 (2000)
Description
「研究成果報告書概要(欧文)」より
-
-
[Publications] Kato J., Fujikawa K., Kanda M., Fukuda N., Sasaki K., Takayama T., Kobune M., Takada K., Takimoto R., Hamada H., Ikeda T. and Niitsu Y.: "A mutation, in the Iron-Responsible Element of H Ferritin mRNA, causing autosomal dominant iron overload"Am. J. Hum. Geagt. 69. 191-197 (2001)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Miyanishi K, Takayama T, Ohi M, Hayashi T, Nobuoka A, Nakajima T, Takimono R, Kogawa K, Kato J, Sakamaki S, and Niitsu Y.: "Glutathione transferase-π overexpression is closely associated.with K-ras mutation during human colon carcinogenesisy."Gastroenterology. 121. 865-874 (2001)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Takayama T., Ohi M., Hayashi T., Miyanishi K., Nobuoka A., Nakajima T., Sato B., Takimoto R., Kato J., Sakamaki S., Niitsu Y.: "Ananlysis of K-ras, APC and β-catenin in aberrnt crypt foci in patients with adenoma and cancer, and familial adenomatous polyposis"Gastroenterology. 121. 599-611 (2001)
Description
「研究成果報告書概要(欧文)」より
-
[Publications] Kato J., Kobune M., Nakamura T., Kuroiwa G., Takada K., Takimoto R., Sato Y., Fujikawa K., Takahashi M., Takayama T., Ikeda T and Niitsu Y.: "Normalization of elevated hepatic 8-hydroxy-2' Deoxyguanosine levels in chronic hepatitis C patients by phrebotomy and low iron diet"Cancer Res. 61. 8697-8702 (2001)
Description
「研究成果報告書概要(欧文)」より
